Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Liver Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Liver Cancer
    TopAbstracts in Liver Cancer 10/29/2009 - (DGNews)
    Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma - (N Engl J Med)
    TopAbstracts in Liver Cancer 10/15/2009 - (DGNews)
    MicroRNA expression, survival, and response to interferon in liver cancer - (N Engl J Med)
    CD4 Cell Count Key to Predicting Risk of Cancers in Patients With HIV - (DGNews)

    News archive

     Recent webcasts/CME - Liver Cancer
    • Evidence-Based Treatment of Intermediate- to Advanced-Stage Hepatocellular Carcinoma: Improving Outcomes With Modern Therapies
    • Focus on Treatment Options and Clinical Issues in Metastatic Hepatocellular Carcinoma
    • Focus on Treatment Options and Clinical Issues in Locally Advanced Hepatocellular Carcinoma
    • Risk of Hepatocellular Carcinoma in Hepatitis B and Prevention Through Treatment

      Webcasts/CME archive

       Recent cases - Liver Cancer
        Complete Pathological Response in a Patient with Multiple Liver Metastases from Colon Cancer Treated with Folfox-6 Chemotherapy Plus Bevacizumab: A Case Report
        Well-Differentiated Gall Bladder Hepatoid Carcinoma Producing Alpha-Fetoprotein: A Case Report
        A Case of Hepatic Angiomyolipoma Difficult to Distinguish from Hepatocellular Carcinoma
        Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review
        Primary Hepatic Embryonal Sarcoma Masquerading as Metastatic Ovarian Cancer

        Cases archive
          




        my personal edition > liver cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Guidelines Support Ablation Techniques for Unresectable Liver Cancer: Presented at NCCN

        By Ed Susman

        HOLLYWOOD, Fla -- March 12, 2008 -- Tumour ablation techniques should play a major role in treating tumours of the liver that are not suitable for resection, according to updated treatment guidelines for hepatocellular carcinoma presented on March 8th here at the National Comprehensive Cancer Network (NCCN) 13th Annual Conference on Clinical Practice Guidelines and Quality Cancer Care.

        "Ablation is a good alternative for small volume disease in cirrhotic liver," said Al B. Benson III, MD, Professor of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

        The new treatment algorithm -- now used throughout the world -- suggests ablation be used in patients who agree to surgery and in those who refuse open surgery.

        If the patient is amenable to surgery, but the lesion is found to be unresectable, Dr. Benson said the guidelines suggest ablation therapy and then further treatment, with the possibility of liver transplantation.

        For patients who are willing to undergo surgery, the guidelines suggest resection and then ablation, if and where necessary.

        Patients who do not agree to an open surgical procedure could be treated with chemotherapy or radiation or could undergo ablation therapy, generally performed percutaneously under radiological guidance.

        In cases where a patient is not a candidate for transplantation, ablation may be considered along with chemoembolisation techniques or enrolment in a clinical trial.

        Dr. Benson said that ablation procedures in localised hepatocellular carcinoma could employ several techniques, including radiofrequency ablation, cryoablation, microwave ablation, interstitial laser therapy, ethanol injection, or acetic acid injection.

        "Chemical or thermal ablation techniques require shorter hospitalisation and cause less damage to the cirrhotic liver," Dr. Benson said. Several studies appear to favour radiofrequency ablation over alcohol ablation therapy, he added.

        Minimally invasive techniques to tackle regional cancers include infusional therapy, chemoembolisation, bland embolisation, radioembolisation, and drug-eluting microspheres.

        "The embolisation therapies are designed to cut off blood supply to the tumour and allow for a longer dwell time of chemotherapeutic agents, and decrease systemic toxicity," he said.

        Selecting the best ablative or embolisation therapy, however, remains more art than science. "Well-performed comparative studies are needed," Dr. Benson concluded.

        [Presentation title: Update Hepatocellular Carcinoma Guidelines.]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send